Liberia-U.S. Clinical Research Partnership Opens Trial to Test Ebola Treatments
NIAID and the Liberian government today launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The randomized controlled trial will take place in Liberia and the United States and will enroll adults and children with known Ebola virus infection.
For more information, visit: http://www.niaid.nih.gov/news/
No hay comentarios:
Publicar un comentario